Literature DB >> 16752048

Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.

T Franck1, R Krueger, D Woitalla, T Müller, S Engelender, O Riess.   

Abstract

Seven in absentia homolog 1 (SIAH-1) is a member of the RING-finger-containing E3 ubiquitin ligases. Two substrates of SIAH-1 are alpha-synuclein and synphilin-1, both of these proteins are involved in Parkinson's disease (PD). Recently, mutations in Parkin, another E3 ubiquitin ligase which ubiquinates synphilin-1 and glycosylated alpha-synuclein, have been defined as a major cause of autosomal recessive PD. The potential role of SIAH-1 in PD is further underlined as SIAH-1 protein is a component of the Lewy bodies and as it plays a role in apoptosis caused by nitric oxide (NO) induced oxidative stress. Thus, we performed a mutation screening of the SIAH-1 gene in PD patients. However, screening a large sample of 209 familial and sporadic PD patients we could not find any disease causing mutation. We therefore conclude that genetic alterations of SIAH-1 do not significantly contribute to the pathogenesis of PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16752048     DOI: 10.1007/s00702-006-0480-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  48 in total

1.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Absence of mutations in the coding region of the alpha-synuclein gene in pathologically proven Parkinson's disease.

Authors:  P Chan; X Jiang; L S Forno; D A Di Monte; C M Tanner; J W Langston
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

3.  Complete genomic screen in Parkinson disease: evidence for multiple genes.

Authors:  W K Scott; M A Nance; R L Watts; J P Hubble; W C Koller; K Lyons; R Pahwa; M B Stern; A Colcher; B C Hiner; J Jankovic; W G Ondo; F H Allen; C G Goetz; G W Small; D Masterman; F Mastaglia; N G Laing; J M Stajich; B Slotterbeck; M W Booze; R C Ribble; E Rampersaud; S G West; R A Gibson; L T Middleton; A D Roses; J L Haines; B L Scott; J M Vance; M A Pericak-Vance
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

4.  Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Authors:  K K Chung; Y Zhang; K L Lim; Y Tanaka; H Huang; J Gao; C A Ross; V L Dawson; T M Dawson
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

Review 5.  Protein S-nitrosylation: purview and parameters.

Authors:  Douglas T Hess; Akio Matsumoto; Sung-Oog Kim; Harvey E Marshall; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-02       Impact factor: 94.444

6.  Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients.

Authors:  Daniela Berg; Marc Niwar; Sylvia Maass; Alexander Zimprich; J Carsten Möller; Ullrich Wuellner; Tanja Schmitz-Hübsch; Christine Klein; Eng-King Tan; Ludger Schöls; Laura Marsh; Ted M Dawson; Bernd Janetzky; Thomas Müller; Dirk Woitalla; Vladimir Kostic; Peter P Pramstaller; Wolfgang H Oertel; Peter Bauer; Rejko Krueger; Thomas Gasser; Olaf Riess
Journal:  Mov Disord       Date:  2005-09       Impact factor: 10.338

7.  Synphilin-1 is present in Lewy bodies in Parkinson's disease.

Authors:  K Wakabayashi; S Engelender; M Yoshimoto; S Tsuji; C A Ross; H Takahashi
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

8.  Neurofilament L gene is not a genetic factor of sporadic and familial Parkinson's disease.

Authors:  Nils Rahner; Carsten Holzmann; Rejko Krüger; Ludger Schöls; Klaus Berger; Olaf Riess
Journal:  Brain Res       Date:  2002-09-27       Impact factor: 3.252

9.  Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease.

Authors:  R Hering; S Petrovic; E-M Mietz; C Holzmann; D Berg; P Bauer; D Woitalla; T Müller; K Berger; R Krüger; O Riess
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

10.  A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization.

Authors:  Darren J Moore; Li Zhang; Ted M Dawson; Valina L Dawson
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

View more
  5 in total

1.  Lotus japonicus E3 ligase SEVEN IN ABSENTIA4 destabilizes the symbiosis receptor-like kinase SYMRK and negatively regulates rhizobial infection.

Authors:  Griet Den Herder; Satoko Yoshida; Meritxell Antolín-Llovera; Martina K Ried; Martin Parniske
Journal:  Plant Cell       Date:  2012-04-24       Impact factor: 11.277

2.  Seven in absentia proteins affect plant growth and nodulation in Medicago truncatula.

Authors:  Griet Den Herder; Annick De Keyser; Riet De Rycke; Stephane Rombauts; Willem Van de Velde; María R Clemente; Christa Verplancke; Peter Mergaert; Eva Kondorosi; Marcelle Holsters; Sofie Goormachtig
Journal:  Plant Physiol       Date:  2008-07-03       Impact factor: 8.340

3.  E3 Ubiquitin Ligase Siah-1 is Down-regulated and Fails to Target Natural HBx Truncates for Degradation in Hepatocellular Carcinoma.

Authors:  Jing Zhao; Jing Wu; Hao Cai; Dan Wang; Long Yu; Wen-Hong Zhang
Journal:  J Cancer       Date:  2016-01-20       Impact factor: 4.207

4.  Transcriptome-wide association study of inflammatory biologic age.

Authors:  Honghuang Lin; Kathryn L Lunetta; Qiang Zhao; Jian Rong; Emelia J Benjamin; Michael M Mendelson; Roby Joehanes; Daniel Levy; Martin G Larson; Joanne M Murabito
Journal:  Aging (Albany NY)       Date:  2017-11-11       Impact factor: 5.682

5.  MicroRNA-193b-3p reduces oxidative stress and mitochondrial damage in rats with cerebral ischemia-reperfusion injury via the seven in absentia homolog 1/Jun N-terminal kinase pathway.

Authors:  Tianye Yang; Jiajun Wu; Kui Ge; Fanlin Wang; Jingxian Fan
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.